Similar articles

• Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

  Kazatchkine MD, Kaveri SV. Kazatchkine MD, et al. N Engl J Med. 2001 Sep 6;345(10):747-55. doi: 10.1056/NEJMra993360. N Engl J Med. 2001. PMID: 11547745 Review. No abstract available.
• Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.

  Kaveri SV, Mouthon L, Kazatchkine MD. Kaveri SV, et al. J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):6-8. doi: 10.1136/jnnp.57.suppl.6. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964857 Free PMC article. Review. No abstract available.
• The science and arts of antibodies.

  Gupta S, Schwarz HP. Gupta S, et al. J Clin Immunol. 2014 Jul;34 Suppl 1:S1-3. doi: 10.1007/s10875-014-0050-3. J Clin Immunol. 2014. PMID: 24760115 No abstract available.
• Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.

  Sibéril S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayry J, Kaveri SV. Sibéril S, et al. Ann N Y Acad Sci. 2007 Sep;1110:497-506. doi: 10.1196/annals.1423.052. Ann N Y Acad Sci. 2007. PMID: 17911465
• IVIG-mediated effector functions in autoimmune and inflammatory diseases.

  Galeotti C, Kaveri SV, Bayry J. Galeotti C, et al. Int Immunol. 2017 Dec 30;29(11):491-498. doi: 10.1093/intimm/dxx039. Int Immunol. 2017. PMID: 28666326 Review.